Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Nat Med. 2007 Nov;13(11):1359-62. Epub 2007 Oct 14.

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins.

Author information

  • 1Satoris, Inc., 2686 Middlefield Road, Suite E, Redwood City, California 94063, USA.

Abstract

A molecular test for Alzheimer's disease could lead to better treatment and therapies. We found 18 signaling proteins in blood plasma that can be used to classify blinded samples from Alzheimer's and control subjects with close to 90% accuracy and to identify patients who had mild cognitive impairment that progressed to Alzheimer's disease 2-6 years later. Biological analysis of the 18 proteins points to systemic dysregulation of hematopoiesis, immune responses, apoptosis and neuronal support in presymptomatic Alzheimer's disease.

PMID:
17934472
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Nature Publishing Group Icon for Faculty of 1000
    Loading ...
    Write to the Help Desk